{"id":78706,"date":"2023-04-19T16:09:47","date_gmt":"2023-04-19T14:09:47","guid":{"rendered":"https:\/\/packaging-journal.de\/?p=78706"},"modified":"2023-04-19T16:09:47","modified_gmt":"2023-04-19T14:09:47","slug":"cooperation-faller-packaging-schubert-pharma","status":"publish","type":"post","link":"https:\/\/packaging-journal.de\/en\/kooperation-faller-packaging-schubert-pharma\/","title":{"rendered":"Cooperation: Faller Packaging and Schubert-Pharma package biopharmaceuticals"},"content":{"rendered":"
\"\"<\/a><\/div><\/div>\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

After the market launch of a new drug, it is a challenge for pharmaceutical manufacturers to calculate production capacities without incurring economic losses. A new solution from Faller Packaging and Schubert-Pharma now helps to minimise the investment risk. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

To obtain marketing authorisation for a drug, pharmaceutical manufacturers must provide packaging that fulfils all typical industry requirements.<\/strong> Every day counts when it comes to the market launch. Because the sooner a product is available everywhere, the sooner patients benefit and the high development costs pay off.<\/p>

However, the production of pharmaceuticals must be quickly adapted to the increasing demand. In the beginning, manually loaded packaging will suffice, a successful launch requires a solution that can be automated as quickly as possible<\/strong>. However, many months can pass before a new authorisation with machine-compatible packaging and the commissioning of a system. Conversely, manufacturers who build up a high production capacity before the launch bear a high investment risk.\u00a0<\/strong><\/p>

\"\"<\/a><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"Faller\t\t\t\t\t\t\t\t\t\t\t
Pharmaceutical manufacturers can already cover a medium packaging volume semi-automatically with the mobile Schubert cobots. (Image: Faller Packaging, Schubert-Pharma)<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

With the right partners, this challenge becomes an economic advantage: Faller Packaging and Schubert-Pharma support manufacturers from Clinical Trial Phase 3 onwards with a customised packaging solution that is already designed for the entire product life cycle. A subsequent format change for the packaging material is therefore not necessary. Karin Kleinbach, Sales Manager at Schubert-Pharma, explains: \u201eOur customers get Seamless service for every level of automation, from launch to series production<\/strong>.\"<\/p>

The experts work with customers to develop pharmaceutical-compliant and fully recyclable carton packaging for all parenterals and a wide variety of dosage forms such as vials, ampoules, syringes, medical devices and combination products. At the same time the cooperation partners plan and realise top-loading packaging processes from manual to fully automated.<\/strong><\/p>